The effects of recombinant human erythropoietin given immediately after delivery to women with anaemia

Current Medical Research and Opinion

Volumn 19, Issue 4, 2003, Pages 346-349

  Hatzis, T ^a,c   Cardamakis, E ^b   Tsapanos, V ^b   Kourounis, G ^b   Linardos, N ^a   Mantouvalos, H ^a   Tzingounis, V ^b  

^a 'Mitera' Maternity and Surgical Center   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c 'Mitera' Matern/Surg Center SA   (Greece)

Author keywords

Anaemia; Erythropoietin; Puerperium; Transfusion

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; SIDE EFFECT; SUPPLEMENTATION;

ADULT; ANEMIA; DELIVERY, OBSTETRIC; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; IRON; POSTOPERATIVE PERIOD; POSTPARTUM PERIOD; PREGNANCY; TREATMENT OUTCOME;

EID: 0038681640     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079903125001802     Document Type: Article

References (13)

1. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann NY Acad Sci 2000;900:125-36
2. Jelkman W. Biology of erythropoietin. Clin Invest 1994;72:S3-S10
3. Faulds D, Sorkin EM. Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anemia and the stimulation of erythropoiesis. Drugs 1989;38:863-99
4. Tong EM, Nissenson AR. Erythropoietin and anemia. Semin Nephrol 2001;21:190-203
5. Abels RI. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol 1992;19(Suppl)8:29-35
6. Mercuriali F, Inghilleri G, Biffi E, et al. Erythropoietin treatment to increase autologous blood donation in patients with low basal hematocrit undergoing elective orthopedic surgery. Clin Invest 1994;72:S16-18
7. Pincus T, Olsen NJ, Russell IJ, et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990;89:161-8
8. Robb N. Concerns of patients, MDs are transforming transfusion medicine. Can Med Assoc J 1996;154:391-6
9. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90
10. Federowicz I, Barrett BB, Andersen JW, et al. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996;36:21-8
11. Guest JF, Munro V, Cookson RF. The annual cost of blood transfusions in the United Kingdom. Clin Lab Haematol 1998;20:111-18
12. Braga J, Marques R, Branco A, et al. Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996;75:449-53
13. Huch R, Huch A. Erythropoietin in obstetrics. Hematol Oncol Clin North Am 1994;8:1021-40